4.5 Article

Obesity and diabetes

期刊

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2023.110773

关键词

Obesity; Diabetes mellitus; Cardiovascular disease; Nonalcoholic fatty liver disease; Antidiabetics; T2DM management

向作者/读者索取更多资源

Obesity, often accompanied by type 2 diabetes (T2DM), is a global epidemic with shared pathophysiological mechanisms. Both conditions involve inflammation, mitochondrial dysfunction, and hyperinsulinemia. Managing obesity-related complications through lifestyle changes, medications, and surgery can improve these conditions as well as related diseases like cardiovascular disease and nonalcoholic fatty liver disease. This review provides an overview of the literature on the association between obesity and T2DM, discussing the shared mechanisms and management approaches.
Obesity, which has currently reached pandemic dimensions, is usually accompanied by diabetes mellitus type 2 (T2DM). These two conditions share common pathophysiological mechanisms. Adipose tissue secretes cytokines which are involved in inflammation and various endocrine functions. As for T2DM, it is characterized also by inflammation, mitochondrial dysfunction, and hyperinsulinemia. These conditions occur also in other diseases related to obesity and T2DM, like cardiovascular disease (CVD) and nonalcoholic fatty liver disease (NAFLD). Thus, management of obesity-related complications with lifestyle modification, anti-obesity drugs, and bariatric surgery, all contribute to improvement in any of these conditions. This review provides an overview of the literature addressing the association between obesity and T2DM, briefly discussing the pathophysiological mechanisms linking these conditions and outlining the management approach at the overlap of obesity and T2DM.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据